Literature DB >> 32812324

Clinical outcomes of laparoscopic-based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistant hypertension caused by unilateral aldosterone-producing adenoma.

Yahui Liu1,2, Binbin Zhu2,3, Lijie Zhu2,3, Linwei Zhao2,3, Degang Ding4, Zhonghua Liu4, Zhiqiang Fan4, Qiuping Zhao2,3, You Zhang2,3,5, Jiguang Wang6, Chuanyu Gao1,2,3.   

Abstract

Previous studies describing renal denervation (RDN) from the intima of the renal artery for the treatment of resistant hypertension have reported variable efficacies, and RDN triggers renal intimal injury and atherosclerosis. This study aimed to evaluate the efficacy and safety of RDN from the adventitia of renal artery plus unilateral laparoscopic adrenalectomy to treat patients with resistant hypertension caused by unilateral aldosterone-producing adenoma (APA). A total of 60 consecutive patients with resistant hypertension caused by unilateral APA were enrolled in this study. Patients were randomly assigned to undergo RDN from the adventitia of the renal artery plus adrenalectomy (RDN group, n = 30) or adrenalectomy alone (control group, n = 30) and were followed up for 12 months. The primary efficacy end point was the change in 24-hours mean ambulatory systolic blood pressure (SBP) from baseline to 12 months. At the 12-month follow-up, the mean reduction of 24-hours average SBP and office SBP in the RDN group was 20.7 ± 15.2 and 37.1 ± 26.0 mm Hg, respectively, which was significantly higher than the mean reduction of 24-hours average SBP (11.9 ± 11.1 mm Hg, P = .017) and the office SBP (25.9 ± 16.8 mm Hg, P = .035) in the control group. Serum potassium levels returned to normal 12 months post-procedure. Patients in the RDN group had higher proportion of cured clinical and biochemical outcomes than those in the control group (35.7% vs 17.9% in clinical outcome; 96.4% vs 89.3% in biochemical outcome, respectively). There were no procedural-, device-, or treatment-related safety events during the 12-month follow-up period between the groups. In conclusion, RDN from the adventitia of the renal artery plus unilateral laparoscopic adrenalectomy is more effective than adrenalectomy alone for treating resistant hypertension caused by unilateral APA.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  aldosterone-producing adenoma; renal denervation; resistant hypertension

Mesh:

Substances:

Year:  2020        PMID: 32812324      PMCID: PMC8029900          DOI: 10.1111/jch.13963

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  36 in total

1.  Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases.

Authors:  Paul Meria; Béatrice Fiquet Kempf; Jean François Hermieu; Pierre François Plouin; Jean Marc Duclos
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

2.  Role of aldosterone in the remnant kidney model in the rat.

Authors:  E L Greene; S Kren; T H Hostetter
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Authors:  Michel Azizi; Roland E Schmieder; Felix Mahfoud; Michael A Weber; Joost Daemen; Justin Davies; Jan Basile; Ajay J Kirtane; Yale Wang; Melvin D Lobo; Manish Saxena; Lida Feyz; Florian Rader; Philipp Lurz; Jeremy Sayer; Marc Sapoval; Terry Levy; Kintur Sanghvi; Josephine Abraham; Andrew S P Sharp; Naomi D L Fisher; Michael J Bloch; Helen Reeve-Stoffer; Leslie Coleman; Christopher Mullin; Laura Mauri
Journal:  Lancet       Date:  2018-05-23       Impact factor: 79.321

4.  Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness.

Authors:  M Stowasser; S A Klemm; T J Tunny; W J Storie; J C Rutherford; R D Gordon
Journal:  Clin Exp Pharmacol Physiol       Date:  1994-04       Impact factor: 2.557

5.  Intravascular imaging, histopathological analysis, and catecholamine quantification following catheter-based renal denervation in a swine model: the impact of prebifurcation energy delivery.

Authors:  Joana Delgado-Silva; Raquel Fernandes; Inês R Pita; Frederico C Pereira; Milosz Jaguszewski; Juan Luis Gutiérrez-Chico; Teresa Ribeiro-Rodrigues; Henrique Girão; Adam Ioannou; Lino Gonçalves
Journal:  Hypertens Res       Date:  2018-07-13       Impact factor: 3.872

6.  Review of surgical management of aldosterone secreting tumours of the adrenal cortex.

Authors:  D A Harris; I Au-Yong; P S Basnyat; G P Sadler; M H Wheeler
Journal:  Eur J Surg Oncol       Date:  2003-06       Impact factor: 4.424

7.  Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.

Authors:  Tracy A Williams; Jacques W M Lenders; Paolo Mulatero; Jacopo Burrello; Marietta Rottenkolber; Christian Adolf; Fumitoshi Satoh; Laurence Amar; Marcus Quinkler; Jaap Deinum; Felix Beuschlein; Kanako K Kitamoto; Uyen Pham; Ryo Morimoto; Hironobu Umakoshi; Aleksander Prejbisz; Tomaz Kocjan; Mitsuhide Naruse; Michael Stowasser; Tetsuo Nishikawa; William F Young; Celso E Gomez-Sanchez; John W Funder; Martin Reincke
Journal:  Lancet Diabetes Endocrinol       Date:  2017-05-30       Impact factor: 32.069

8.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

9.  Laparoscopic-based perivascular unilateral renal sympathetic nerve denervation for treating resistant hypertension: a case report.

Authors:  Chuanyu Gao; Linwei Zhao; Lijie Zhu; Muwei Li; Degang Ding; Zhonghua Liu; Zhiqiang Fan; You Zhang; Wenli Zhao; Jiguang Wang
Journal:  Hypertens Res       Date:  2019-02-27       Impact factor: 3.872

10.  Clinical outcomes of laparoscopic-based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistant hypertension caused by unilateral aldosterone-producing adenoma.

Authors:  Yahui Liu; Binbin Zhu; Lijie Zhu; Linwei Zhao; Degang Ding; Zhonghua Liu; Zhiqiang Fan; Qiuping Zhao; You Zhang; Jiguang Wang; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

View more
  5 in total

1.  The Effect of Renal Denervation on Cardiac Diastolic Function in Patients with Hypertension and Paroxysmal Atrial Fibrillation.

Authors:  Hai Xu; Zhixin Jiang; Wanying Jiang; Junyu Huo; Qijun Shan
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-28       Impact factor: 2.650

2.  Primary aldosteronism: Involvement of sympathetic system in the persistence of hypertension after surgery.

Authors:  Decio Armanini; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

3.  Reply.

Authors:  Yahui Liu; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-29       Impact factor: 3.738

4.  Clinical outcomes of laparoscopic-based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistant hypertension caused by unilateral aldosterone-producing adenoma.

Authors:  Yahui Liu; Binbin Zhu; Lijie Zhu; Linwei Zhao; Degang Ding; Zhonghua Liu; Zhiqiang Fan; Qiuping Zhao; You Zhang; Jiguang Wang; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

5.  Thirty-six-month results of laparoscopic-based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone-producing adenoma.

Authors:  Yahui Liu; Binbin Zhu; Lijie Zhu; Linwei Zhao; Zhiqiang Fan; Degang Ding; Zhonghua Liu; Qiuping Zhao; Datun Qi; You Zhang; Ji-Guang Wang; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-16       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.